Centre & Arvind Kejriwal government still stuck on name for Ayushman Bharat

Should ‘Ayushman Bharat’ be the suffix or the prefix of the name of the scheme in Delhi – that seems to be one of the issues stopping the rollout of the mega health protection scheme in Delhi.

ET has learnt that the Arvind Kejriwal government, in late August, told the Centre that the state health minister, Satyendra Kumar Jain, had “approved” entering into a memorandum of understanding (MoU) with the Centre regarding the scheme. But the state government wanted the name of the scheme to be ‘Mukhya Mantri Aam Aadmi Swasthya Bima Yojana Ayushman Bharat’. The Centre is said to have written back to the state government on August 28, saying it was critical that the name of the scheme start with ‘Ayushman Bharat’ since it was a “national scheme with national character” and that the state government could have any suffix after ‘Ayushman Bharat’.

“We are yet to hear from the Delhi government post that communication,” said a senior central government official, speaking on condition of anonymity. A Delhi government spokesperson said the state had agreed “in principle” to the scheme and that the issue of the name “was a minor one”. He said the Centre was itself offering “flexibility” to states in naming the scheme and Punjab had changed the name of the scheme as well. Congress-ruled Punjab signed an MoU with the Centre on the scheme on Wednesday. “The real issue is that the Centre’s ceiling in Ayushman scheme covers only 6% of Delhi’s population,” said the Delhi government spokesperson.

With the MoU with Delhi still elusive, the Centre has opened up a parallel channel as well to ensure Delhi’s residents are not deprived of the scheme. On Thursday it held a meeting with representatives from 45 leading private hospitals in Delhi including Apollo, Fortis and Max who are part of the National Accreditation Board for Hospitals and Healthcare Providers (NABH), to motivate them to join the scheme as well. “It was a good meeting and many private hospitals in Delhi have also shown interest in joining the scheme,” said a central government official.

The Centre has empanelled three prominent central government hospitals in Delhi – AIIMS, Safdarjung Hospital and Ram Manohar Lohia Hospital – under Ayushman Bharat this month by entering into separate MoUs with them. So these hospitals are now offering medical insurance cover under the Ayushman scheme to eligible patients.

All states and Union territories, except Kerala, Telangana, Odisha and Delhi, have rolled out Ayushman Bharat scheme. Karnataka and Punjab joined the scheme after the country-wide launch on September 23. Kerala is expected to sign an MoU with the Centre next week while Telangana is said to be ready to sign one after the assembly election this December. According to the Centre, more than 79,000 patients have been admitted for treatment across the country in the past 25 days and claims of more than Rs 101 crore have been approved under the scheme.

  • Related Posts

    MNCs seek restart of refurbished medical device imports

    New Delhi, August 19, 2025 — Global med-tech companies have urged the Centre to allow refurbished medical device imports again and include medical devices in India’s repair-services push. The request…

    Kerala’s Disease Surge Tied to Poor Hygiene and Climate Stress

    Thiruvananthapuram, August 19, 2025 — Kerala is seeing a sharp rise in communicable diseases as poor sanitation, stagnant water, and changing weather patterns create ideal conditions for outbreaks. Public-health experts…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    Diabetic drug metformin found to act on brain

    Diabetic drug metformin found to act on brain

    Hetero debuts semaglutide generic in emerging markets

    Hetero debuts semaglutide generic in emerging markets

    LB Pharma Begins Pivotal Phase 3 Schizophrenia Trial

    LB Pharma Begins Pivotal Phase 3 Schizophrenia Trial

    Check manufacturing, sale of 26 unapproved drugs, central regulator tells state authority

    Check manufacturing, sale of 26 unapproved drugs, central regulator tells state authority

    Stem cell therapy for autism illegal: NMC advisory

    Stem cell therapy for autism illegal: NMC advisory

    India’s Essential Medicines Prices To Increase Marginally From 1 April Under Annual Pricing Framework

    India’s Essential Medicines Prices To Increase Marginally From 1 April Under Annual Pricing Framework